PARP-1 initiated neuronal cell death pathway–do androgens matter?
暂无分享,去创建一个
S. Murphy | P. Hurn | K. Vagnerová | A. Ardeshiri | S. P | K. Liu | J. Cheng | Herson
[1] Jian Cheng,et al. Dose-Dependent Effects of Androgens on Outcome after Focal Cerebral Ischemia in Adult Male Mice , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[2] L. McCullough,et al. Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke , 2009, Experimental Neurology.
[3] P. Hurn,et al. Sex, Sex Steroids, and Brain Injury , 2009, Seminars in reproductive medicine.
[4] L. McCullough,et al. Sex Differences in Minocycline-Induced Neuroprotection after Experimental Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] C. Szabó,et al. Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease. , 2008, The American journal of pathology.
[6] P. Hurn,et al. Gender and the Injured Brain , 2008, Anesthesia and analgesia.
[7] L. McCullough,et al. Pathways to ischemic neuronal cell death: are sex differences relevant? , 2008, Journal of Translational Medicine.
[8] F. Moroni. Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage. , 2008, Current opinion in pharmacology.
[9] N. Alkayed,et al. Deleterious Effects of Dihydrotestosterone on Cerebral Ischemic Injury , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] R. Swanson,et al. Use of a Poly(ADP-Ribose) Polymerase Inhibitor to Suppress Inflammation and Neuronal Death After Cerebral Ischemia-Reperfusion , 2007, Stroke.
[11] R. Swanson,et al. Novel modulators of poly(ADP-ribose) polymerase. , 2006, Trends in pharmacological sciences.
[12] P. Hurn,et al. Sigma 1 Receptor Agonists Act as Neuroprotective Drugs Through Inhibition of Inducible Nitric Oxide Synthase , 2006, Anesthesia and analgesia.
[13] Changlian Zhu,et al. Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia–ischaemia , 2006, Journal of neurochemistry.
[14] Michael M. Wang,et al. Sex differences in cell death , 2005, Annals of neurology.
[15] Csaba Szabó,et al. Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors , 2005, Nature Reviews Drug Discovery.
[16] L. McCullough,et al. Ischemic Nitric Oxide and Poly (ADP-Ribose) Polymerase-1 in Cerebral Ischemia: Male Toxicity, Female Protection , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[17] S. Vannucci,et al. Adult or Perinatal Brain Injury: Does Sex Matter? , 2005, Stroke.
[18] Changlian Zhu,et al. PARP‐1 gene disruption in mice preferentially protects males from perinatal brain injury , 2004, Journal of neurochemistry.
[19] A. LeBlanc,et al. Estrogen and Androgen Protection of Human Neurons against Intracellular Amyloid β1-42 Toxicity through Heat Shock Protein 70 , 2004, The Journal of Neuroscience.
[20] V. Tomassini,et al. Testosterone amplifies excitotoxic damage of cultured oligodendrocytes , 2004, Journal of neurochemistry.
[21] A. LeBlanc,et al. Testosterone‐mediated neuroprotection through the androgen receptor in human primary neurons , 2001, Journal of neurochemistry.
[22] G. Prins,et al. Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism , 2001, Brain Research.
[23] P. Hurn,et al. Estrogen as a Neuroprotectant in Stroke , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[24] S. Lu,et al. Neural androgen receptor regulation: effects of androgen and antiandrogen. , 1999, Journal of neurobiology.
[25] B. Zhivotovsky,et al. Androgen treatment of neonatal rats decreases susceptibility of cerebellar granule neurons to oxidative stress in vitro , 1999, The European journal of neuroscience.
[26] R. Traystman,et al. Estrogen-mediated neuroprotection after experimental stroke in male rats. , 1998, Stroke.
[27] A. Day,et al. Testosterone increases and estradiol decreases middle cerebral artery occlusion lesion size in male rats , 1998, Brain Research.
[28] S. Snyder,et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia , 1997, Nature Medicine.
[29] R. Traystman,et al. Postischemic Brain Injury Is Affected Stereospecifically by Pentazocine in Rats , 1997, Anesthesia and analgesia.
[30] Daniel B Hier,et al. The Stroke Data Bank: design, methods, and baseline characteristics. , 1988, Stroke.
[31] A. Day,et al. Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model. , 2002, Journal of applied physiology.
[32] K. Murthy,et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation , 2001, Nature Medicine.
[33] V. Dawson,et al. Neuroprotective effect of sigma(1)-receptor ligand 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP) is linked to reduced neuronal nitric oxide production. , 2001, Stroke.
[34] R. Traystman,et al. Postischemic cerebral blood flow recovery in the female: effect of 17 beta-estradiol. , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.